Category: General Biotechnology

Kyle Bass: The U.S. Still Has A Drug Problem

To date, the Patent Trial and Appeal Board has reached a final decision in eight instituted inter partes review (IPR) challenges, including seven IPRs filed by the Coalition for Affordable Drugs and one IPR filed by Erich Spangenberg and me personally on a not-for-profit basis. The outcomes were favorable in seven of the eight IPRs. […]



Drug Patent Expirations for Nov 10, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AXUMIN (fluciclovine f-18) Blue Earth Patent number: 5,808,146 Expiration Date: Nov 9, 2016 GADAVIST (gadobutrol) Bayer Hlthcare Patent number: 5,980,864 Expiration Date: Nov 9, 2016 BROVANA […]


Click here for reuse options!
Copyright 2016 Biotechblog

Drug Patent Expirations for Nov 3, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. NEXIUM (esomeprazole magnesium) Astrazeneca Pharms Patent number: 5,900,424 Expiration Date: Nov 4, 2016 VIMOVO (esomeprazole magnesium; naproxen) Horizon Pharma Usa Patent number: 5,900,424 Expiration Date: Nov […]


Click here for reuse options!
Copyright 2016 Biotechblog

Americans say lowering drug costs is a top priority

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is highlighted by a significant milestone for our shortest person, who turns another page in the book of life. And so, we will […]



Addressing the Challenges of Pharmaceutical Distribution in International Markets

This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below. If domestic pharmaceutical distribution is complex, international distribution is considerably more complicated International growth markets for pharmaceuticals represent enormous opportunities, but they also bring their own unique challenges, including infrastructure, fragmented distribution, and a patchwork […]


Click here for reuse options!
Copyright 2016 Biotechblog

How to get new drugs to consumers faster and affordably

By Devon Herrick / NCPA House Minority Leader Nancy Pelosi actually agrees on one thing with Speaker Paul Ryan and Senate Majority Leader Mitch McConnell. All three support the 21st Century Cures Act. There is no word about whether Pelosi has actually read the bill. Maybe she wants to pass it to find out what’s […]



A Cuban Lung Cancer Vaccine Makes History In the U.S.

A new Cuban lung cancer vaccine is coming to the United States, the Roswell Park Cancer Center announced Wednesday. The U.S. Food and Drug Administration approved a clinical trial for the vaccination at the center in Buffalo, New York, marking the first time a Cuban-made therapy will be available for patients in the U.S. The […]



Drug Patent Expirations for Oct 27, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AZOR (amlodipine besylate; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration Date: Oct 25, 2016 BENICAR HCT (hydrochlorothiazide; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration […]


Click here for reuse options!
Copyright 2016 Biotechblog

Drug Patent Expirations for Oct 27, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AZOR (amlodipine besylate; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration Date: Oct 25, 2016 BENICAR HCT (hydrochlorothiazide; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration […]


Click here for reuse options!
Copyright 2016 Biotechblog

Drug Patent Expirations for Oct 27, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AZOR (amlodipine besylate; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration Date: Oct 25, 2016 BENICAR HCT (hydrochlorothiazide; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration […]


Click here for reuse options!
Copyright 2016 Biotechblog

%d bloggers like this: